Stephen Ansell, MD, PhD, from the Mayo Clinic, Rochester, MN, USA, briefly describes the effectiveness and recent approval of immune checkpoint therapies in treating lymphoma for patients in the US and in Europe, noting that this new form of therapy will be accessible to patients in the distant future. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.